Cargando…
Prescription opioids and economic hardship in France
This paper studies how opioid analgesic sales are empirically related to socioeconomic disparities in France, with a focus on poverty. This analysis is made possible using the OpenHealth database, which provides retail sales data for opioid analgesics available on the French market. We exploit firm-...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884604/ https://www.ncbi.nlm.nih.gov/pubmed/36710287 http://dx.doi.org/10.1007/s10198-022-01557-4 |
_version_ | 1784879752412135424 |
---|---|
author | Natali, Ilaria Dewatripont, Mathias Ginsburgh, Victor Goldman, Michel Legros, Patrick |
author_facet | Natali, Ilaria Dewatripont, Mathias Ginsburgh, Victor Goldman, Michel Legros, Patrick |
author_sort | Natali, Ilaria |
collection | PubMed |
description | This paper studies how opioid analgesic sales are empirically related to socioeconomic disparities in France, with a focus on poverty. This analysis is made possible using the OpenHealth database, which provides retail sales data for opioid analgesics available on the French market. We exploit firm-level data for each of the 94 departments in Metropolitan France between 2008 and 2017. We show that increases in the poverty rate are associated with increases in sales: a one percentage point increase in poverty is associated with approximately a 5% increase in mild opioid sales. Our analysis further shows that opioid sales are positively related to the share of middle-aged people and individuals with basic education only, while they are negatively related to population density. The granularity and longitudinal nature of these data allow us to control for a large pool of potential confounding factors. Our results suggest that additional interventions should be more intensively addressed toward the most deprived areas. We conclude that a combination of policies aimed at improving economic prospects and strictly monitoring access to opioid medications would be beneficial for reducing opioid-related harm. |
format | Online Article Text |
id | pubmed-9884604 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-98846042023-01-30 Prescription opioids and economic hardship in France Natali, Ilaria Dewatripont, Mathias Ginsburgh, Victor Goldman, Michel Legros, Patrick Eur J Health Econ Original Paper This paper studies how opioid analgesic sales are empirically related to socioeconomic disparities in France, with a focus on poverty. This analysis is made possible using the OpenHealth database, which provides retail sales data for opioid analgesics available on the French market. We exploit firm-level data for each of the 94 departments in Metropolitan France between 2008 and 2017. We show that increases in the poverty rate are associated with increases in sales: a one percentage point increase in poverty is associated with approximately a 5% increase in mild opioid sales. Our analysis further shows that opioid sales are positively related to the share of middle-aged people and individuals with basic education only, while they are negatively related to population density. The granularity and longitudinal nature of these data allow us to control for a large pool of potential confounding factors. Our results suggest that additional interventions should be more intensively addressed toward the most deprived areas. We conclude that a combination of policies aimed at improving economic prospects and strictly monitoring access to opioid medications would be beneficial for reducing opioid-related harm. Springer Berlin Heidelberg 2023-01-30 2023 /pmc/articles/PMC9884604/ /pubmed/36710287 http://dx.doi.org/10.1007/s10198-022-01557-4 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Paper Natali, Ilaria Dewatripont, Mathias Ginsburgh, Victor Goldman, Michel Legros, Patrick Prescription opioids and economic hardship in France |
title | Prescription opioids and economic hardship in France |
title_full | Prescription opioids and economic hardship in France |
title_fullStr | Prescription opioids and economic hardship in France |
title_full_unstemmed | Prescription opioids and economic hardship in France |
title_short | Prescription opioids and economic hardship in France |
title_sort | prescription opioids and economic hardship in france |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884604/ https://www.ncbi.nlm.nih.gov/pubmed/36710287 http://dx.doi.org/10.1007/s10198-022-01557-4 |
work_keys_str_mv | AT nataliilaria prescriptionopioidsandeconomichardshipinfrance AT dewatripontmathias prescriptionopioidsandeconomichardshipinfrance AT ginsburghvictor prescriptionopioidsandeconomichardshipinfrance AT goldmanmichel prescriptionopioidsandeconomichardshipinfrance AT legrospatrick prescriptionopioidsandeconomichardshipinfrance |